Found 10 matching trials
Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG) PHASE2 The purpose of the protocol is to evaluate the correlation between plasma l...
Show More Location
Centro Médico Nacional Siglo XXI, IMSS
Learn More & Join Trial
Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy PHASE4 The purpose of our study is to evaluate the efficacy and safety of Lanreoti...
Show More Location
Pediatric Endocrinology Unit, Sheba Medical Center
Learn More & Join Trial
Somatuline Predictive Factors in Acromegaly and NET N/A The aim of the study is to identify predictive factors for the response to ...
Show More Location
University Hospital of Vienna
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly PHASE4 Recently, a new formulation of lanreotide, lanreotide Autogel (ATG) 60 mg, ...
Show More Learn More & Join Trial
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors. PHASE2 The purpose of the protocol is to evaluate the efficacy and safety of Lanre...
Show More Location
Oncologia Medica - Istituto Oncologico del Mediterraneo - IOM
Learn More & Join Trial
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) PHASE1 This is an open-label, single treatment arm, multicenter study to assess th...
Show More Location
Rigshospitalet, Endokrinologisk afdeling
Learn More & Join Trial
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET PHASE3 The purpose of this study is to compare the effectiveness and safety of CAM...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Cancer Center (MCCC) - Phoenix
Learn More & Join Trial
The MetNET-2 Trial EARLY_PHASE1 This is a Pilot, One-arm, Open-label, Prospective Study to evaluate Safety ...
Show More Learn More & Join Trial
Predictive Factors Study N/A This is a long term study to evaluate common therapeutic algorithms and pos...
Show More Location
St Vincent's Hospital
Learn More & Join Trial